According to MedImmune, the AstraZeneca subsidiary that makes FluMist, studies have shown that people ages 18 to 49 can successfully give the vaccine, and it's just as effective as having a doctor ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
Some results have been hidden because they may be inaccessible to you